Intralesional Bevacizumab (Avastin®) as a Novel Addition to Infantile Hemangioma Management: A Medical Hypothesis

Infantile hemangiomas (IHs) are benign tumors of the vascular endothelium. There are numerous medications available for the treatment of IH, including wait‑and‑see policy, laser therapy, systemic and local medications, sclerotherapy, radiotherapy, and surgery. To obtain the best treatment outcomes, the treatment protocol should be individualized and comprehensive as well as sequential

Avastin; Infantile Hemangioma